We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
DADC
51
D.A. Davidson & Co
Montana
$1.86M +$334K +32,760 +19%
Ameriprise
52
Ameriprise
Minnesota
$1.79M +$289K +28,314 +17%
Tudor Investment Corp
53
Tudor Investment Corp
Connecticut
$1.78M +$1.99M +194,874 New
CM
54
Crestline Management
Texas
$1.7M +$847K +82,921 +81%
PAMP
55
Polar Asset Management Partners
Ontario, Canada
$1.66M +$1.86M +182,200 New
PPA
56
Parametric Portfolio Associates
Washington
$1.6M -$26.5K -2,594 -1%
APP
57
Alpha Paradigm Partners
Illinois
$1.58M +$1.12M +109,952 +173%
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$1.51M -$20.8K -2,040 -1%
ECM
59
Endurant Capital Management
California
$1.51M +$1.69M +165,404 New
MF
60
Magnetar Financial
Illinois
$1.51M +$72.6K +7,113 +5%
Toronto Dominion Bank
61
Toronto Dominion Bank
Ontario, Canada
$1.49M +$1.67M +163,376 +1,815,289%
BNP Paribas Financial Markets
62
BNP Paribas Financial Markets
France
$1.4M +$1.39M +136,197 +811%
Ensign Peak Advisors
63
Ensign Peak Advisors
Utah
$1.4M +$304K +29,740 +24%
CS
64
Credit Suisse
Switzerland
$1.31M +$356K +34,846 +32%
Barclays
65
Barclays
United Kingdom
$1.29M +$570K +55,786 +65%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$1.2M +$26.5K +2,595 +2%
Fisher Asset Management
67
Fisher Asset Management
Washington
$1.2M +$985K +96,487 +276%
AllianceBernstein
68
AllianceBernstein
Tennessee
$1.18M -$144K -14,100 -10%
Jane Street
69
Jane Street
New York
$1.17M +$729K +71,428 +127%
Fidelity Investments
70
Fidelity Investments
Massachusetts
$1.16M -$5.24M -513,632 -80%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$1.08M – – –
CSS
72
Cubist Systematic Strategies
Connecticut
$1.07M +$309K +30,286 +35%
UBS AM
73
UBS AM
Illinois
$1.01M +$133K +13,069 +13%
Wells Fargo
74
Wells Fargo
California
$951K -$663K -64,977 -38%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$941K -$19.8K -1,941 -2%
1 2
3
4 5

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.